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1. Introduction 
Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) (OMIM #270550) was 
originally found among inhabitants of the Charlevoix-Saguenay region of Quebec 
(Bouchard et al., 1978). ARSACS patients in Quebec show uniform phenotypes characterized 
by early-onset spastic ataxia, peripheral neuropathy, retinal hypermyelination, hand or foot 
deformities, and normal mentality. In 2000, the SACS gene, which is responsible for 
ARSACS, was identified in Quebec patients (Engert et al., 2000). Since then, ARSACS has 
been reported worldwide, especially in the Mediterranean area (El Euch-Fayache et al., 2003; 
Criscuolo et al., 2004; Grieco et al., 2004; Richter et al., 2004) and Japan (Ogawa et al., 2004; 
Takiyama, 2006). More SACS gene mutations were also identified in other areas (Takiyama, 
2007; Ouyang et al., 2008; Vermeer et al., 2008; Gerwig et al., 2010). Meanwhile, ARSACS in 
non-Quebec patients, especially in Japanese ones, showed marked clinical heterogeneity, 
i.e., there were patients without spasticity (Shimazaki et al., 2005; Hara et al., 2007; 
Shimazaki et al., 2007), without retinal hypermyelination (Hara et al., 2007), and with 
decreased mentality (Shimazaki et al., 2005; Yamamoto et al., 2005; Shimazaki et al., 2007; 
Hara et al., 2005). The clinical spectrum of the sacsinpathies will expand with the 
identification of more SACS gene mutations (Gomez, 2004).  
We herein review the epidemiology, genetics, clinical phenotypes, radiological and 
pathological findings in ARSACS cases carrying mutations of the SACS gene. 
2. Epidemiology 
2.1 Quebec 
ARSACS is the most common of all inherited spastic ataxias, 320 affected patients having 
been identified in Quebec (Bouchard et al., 1998). In Quebec, most of the patients’ families 
originate from the Charlevoix and Saguenay-Lac-St. Jean (SLSJ) regions. These regions have 
a population of about 300,000 inhabitants today that share a limited number of French 
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ancestors who settled first in the Charlevoix region back in the seventeenth and early 
eighteenth centuries. ARSACS affects 1/1519 individuals in Charlevoix and 1/1952 in the 
Saguenay-Lac-St. Jean region, where the carrier frequency was estimated to be 1/22 for the 
1941-1985 period (De Braekeleer et al., 1993). 
2.2 Non-Quebec 
SACS gene identification has enabled us to find ARSACS patients worldwide outside 
Quebec: Tunisia (El Euch-Fayache et al., 2003) in 2003, Italy (Criscuolo et al., 2004; Grieco et 
al., 2004)in 2004, Japan (Ogawa et al., 2004) in 2004, and Turkey (Richter et al., 2004) in 2004. 
More cases were then reported in Spain (Criscuolo et al., 2005), France (Anheim et al., 2008), 
Belgium (Ouyang et al., 2008), the Netherlands (Vermeer et al., 2008), Germany (Gerwig et 
al., 2010), Maritime Canada (Guernsey et al., 2010), and Morocco and eastern Europe (Baets 
et al., 2010). In eastern France, ARSACS was identified in two index patients among 102 
autosomal recessive cerebellar ataxia (ARCA) ones (Anheim et al., 2008), meanwhile among 
43 Dutch ARCA patients, 16 with mutations in the SACS gene were identified (Vermeer et 
al., 2008). In Japan, 17 Japanese ARSACS families have been discovered on SACS gene 
analysis so far (Ogawa et al., 2004; Hara et al., 2005; Shimazaki et al., 2005; Yamamoto et al., 
2005; Ouyang et al., 2006; Yamamoto et al., 2006; Okawa et al., 2006; Hara et al., 2007; 
Takado et al., 2007; Shimazaki et al., 2007; Kamada et al., 2008; Tsugawa et al., 2009; Haga et 
al., 2011; Miyatake et al., 2011; Komure et al., 2006). ARSACS might be the second most 
frequent ARCA next to ataxia with oculomotor apraxia 1 (AOA1) in Japan. Figure 1 shows 
the geographical distribution and numbers of ARSACS families with SACS gene mutations 
in Japan. We could not find apparent regional accumulation of ARSACS families in Japan. 
Table 1 lists the previously identified SACS gene mutations that we could confirm in the 17 
Japanese ARSACS families. The mutations were unique ones for each family except for one 
missense mutation (W3248R) found in two unrelated families.  
 
Fig. 1. Regional distribution of ARSACS families in Japan.  
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ARSACS families show a nationwide distribution in Japan. The numbers in circles are the 
numbers of families identified in the regions.  
Amino acid substitutions Exon family references 
W3248R 10 2 Ogawa, 2004, Takiyama, 2006 
K2931fsX2952 10 1 Hara, 2005 
F1054S 10 1 Shimazaki, 2005 
G1734fsX1736 10 
1 Yamamoto, 2005 
S2058fsX2076 10 
V1231del 10 
1 Komure, 2006 
P3559L 10 
Q1345X 10 1 Okawa, 2006 
R4325X 10 1 Yamamoto, 2006 
C395fsX407 8 
1 Ouyang, 2006 
D687fsX713 8 
R2119X 10 1 Hara, 2007 
L308F 8 1 Takado, 2007 
D1996fsX1999 10 1 Shimazaki, 2007 
N161fsX175 7 
1 Kamada, 2008 
L802P 10 
G1257X 10 
1 Tsugawa, 2009 
R3788fsX3820 10 
Y138X 6 
1 Haga, 2011 
K1755fsX1775 10 
R3636X 10 1 (unpublished) 
S4007F 10 1 Miyatake, 2011 
 
Table 1. Previously identified SACS gene mutations in Japanese patients. 
3. Genetics 
3.1 Gene structure and pathological mutations 
The SACS gene was originally reported to consist of a single gigantic exon spanning 
12,794bp encoding an 11,487bp open reading frame (ORF), which represents the largest exon 
and the largest ORF within an exon found in any vertebrate (Engert et al., 2000). Recently, 
eight new exons located upstream of the gigantic one were found (Ouyang et al., 2006). 
More recently, one more upstream non-coding exon was found (Genbank NG_012342, 13-
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MAR-2011). The SACS gene comprises ten exons with a 13,737 bp ORF encoding 4579 amino 
acids (Figure 2A).  
The SACS gene is predicted to encode a 520-kDa multidomain protein, sacsin. The region 
near the C-terminus exhibits sequence similarity to the J-domain (DnaJ motif) of heat shock 
protein (HSP) 40 proteins (Parfitt et al., 2009), and the higher eukaryote and prokaryote 
nucleotide-binding (HEPN) domain (Grynberg, Erlandsen, and Godzik, 2003) (Figure 2B). A 
ubiquitin-like domain was identified at the N-terminus of sacsin (Parfitt et al., 2009)(Figure 
2B). A sacsin repeating region (SRR) is present in triplicate at the N-terminus of sacsin 
(Anderson, Siller, and Barral, 2010). A xeroderma pigmentosum complementation group C-
binding (XPCB) domain (Kamionka and Feigon, 2004) upstream of the DnaJ domain is also 
predicted.  
 
Fig. 2. Primary structure of the SACS gene (A) and domain organization of the sacsin 
protein (B). UBL: ubiquitin-like domain; SRR: sacsin repeating region; XPCB: XPC-binding 
domain; DnaJ: DnaJ motif (adopted from (Kozlov et al., 2011)). 
Seventy-four mutations have been reported as pathological ones in the SACS gene (Baets et 
al., 2010). After publication of that report, we verified the table and found seven additional 
mutations in exons 6 and 10 of the SACS gene in Japanese  patients (Table 1) (Komure et al., 
2006; Tsugawa et al., 2009; Haga et al., 2011; Miyatake et al., 2011). As far as we know, at 
least 81 mutations have been found worldwide to date. Most of the mutations are predicted 
to generate truncated sacsin proteins, and are located in the largest exon, 10. Seventeen 
mutations were found in exons 4, 6, 7, 8 and 9. On copy number variation (CNV) analysis, 
an intragenic SACS deletion of exons 3-5 was identified (Baets et al., 2010). Two types of 
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large deletions of the whole SACS gene and adjacent genes have been reported (Breckpot et 
al., 2008; Terracciano et al., 2009; McMillan et al., 2009).  
3.2 Normal sacsin function 
Sacsin is highly expressed in neurons, especially in cerebral corticospinal neurons and 
cerebellar Purkinje cells (Parfitt et al., 2009). The subcellular localization of sacsin in a 
cultured neuroblastoma-derived cell line was predominantly cytoplasmic and overlapped 
with that of mitochondrial protein heat shock protein (HSP) 60 (Parfitt et al., 2009). 
Because sacsin contains a functional J-domain (DnaJ motif), it has been proposed to act as 
a co-chaperone of the HSP70 chaperone system (Parfitt et al., 2009). The N-terminal 
segment of sacsin containing the ubiquitin-like (UbL) domain and the first sacsin 
repeating region (SRR) exhibits molecular chaperone activity and ATP-hydrolyzing 
activity (Anderson, Siller, and Barral, 2010, 2011). The UbL domain can interact with the 
20 S proteasomal subunit (Parfitt et al., 2009). The HSP70 chaperone machinery is an 
important component of the cellular response to aggregation prone mutant proteins, and 
the UbL domain protein is a part of the quality control machinery that regulates protein 
aggregation. Overall, the main function of sacsin, like other molecular chaperones, is 
probably to prevent protein misfolding and aggregation. Sacsin prevents polyglutamine-
expanded ataxin-1 toxicity (Parfitt et al., 2009). The XPCB domain interacts with ataxin-3, 
which is involved in spinocerebellar ataxia type 3 (Kamionka and Feigon, 2004). HEPN 
may stabilize nucleotide binding in complexes formed with the DnaJ domain (Grynberg, 
Erlandsen, and Godzik, 2003). Recently, the structure and function of the HEPN domain 
were determined, it being shown that it dimerizes and has a high affinity binding site for 
GTP, but it does not have GTPase activity (Kozlov et al., 2011).  
3.3 Pathogenesis of ARSACS 
Although the molecular mechanism underlying ARSACS remains unclear, the autosomal 
recessive transmission and truncating nature of most SACS mutations suggest the loss of 
sacsin function might cause development of this disease. Several functional alterations of 
sacsin proteins have been reported. An aspartate to tyrosine mutation (D168Y), located in 
the first SSR domain, abrogates its ATP-hydrolyzing activity (Anderson, Siller, and Barral, 
2010). An asparagine to aspartate mutation (N4549D) in the HEPN domain of the sacsin 
protein disrupts dimerization and correct protein folding (Kozlov et al., 2011). Premature 
termination of other mutations and loss of the HEPN domain might lead to ARSACS 
disease.  
4. Clinical phenotypes 
4.1 Original Quebec phenotype 
ARSACS is clinically characterized by early-onset spastic ataxia, axonal and 
demyelinating neuropathy, and hypermyelination of retinal nerve fibers (Bouchard et 
al., 1978; Bouchard, 1991). Unsteadiness of gait is usually the initial symptom. None of 
the patients ever walk normally, but walking is not delayed in most cases (rarely 
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beyond 18 months of age) (Bouchard et al., 1978; Bouchard, 1991). The disease 
progression becomes most obvious in the late teens or early twenties, and the mean age 
for patients becoming wheelchair-bound is 41 years in Quebec patients (Bouchard, 
1991). Concerning Quebec patients, ataxia, dysarthria, nystagmus, Babinski sign, 
hyperreflexia, spasticity, and retinal striations are noted in all of them. Distal 
amyotrophy of the feet is present in all patients after 20 years old (Bouchard, 1991), and 
pes cavus is noted in most Quebec patients. With these clinical features, ARSACS is 
clinically homogeneous in Quebec patients. Bouchard described progressive signs and 
early non-progressive ones of ARSACS in a review of this disease (Bouchard, 1991). The 
progressive signs are mostly spastic ataxia of the four limbs, slurred and dysrhythmic 
speech, discrete to severe distal amyotrophy, and absent ankle jerks after 25 years of 
age. The early non-progressive signs are increased deep tendon reflexes, a bilateral 
abnormal plantar response, marked saccadic alteration of smooth pursuit, and 
prominent myelinated fibers radiating from the disc on the retina.  
4.2 Non-Quebec atypical phenotypes 
The mean ages at onset are 5.4 and 4.5 years old in Japanese and Tunisian patients, 
respectively (Takiyama, 2007), while the ages at onset range from one to 1.5 years old in 
Quebec ones (Bouchard, 1991). Thus, the age at onset in these non-Quebec patients seems to 
be later than that in Quebec patients. According to a recent report from Belgium, the disease 
onset was over 20 years in five patients and as late as 40 years in one patient (Baets et al., 
2010).  
Although ataxia is noted in all non-Quebec ARSACS patients, one report stated that the 
cerebellar features were very mild in two patients (Baets et al., 2010). Other core clinical 
features of ARSACS, i.e., dysarthria, nystagmus, distal amyotrophy, Babinski sign, 
hyperreflexia, and pes cavus, are noted in most non-Quebec patients, which are similar to in 
Quebec patients.  
Non-Quebec patients, however, show some atypical features in comparison with Quebec 
ones. First, although spasticity is a core clinical feature of ARSACS, we found that two 
patients in a Japanese family with ARSACS lacked spasticity in the legs and showed 
areflexia or hyporeflexia (Shimazaki et al., 2005). In Quebec and Tunisian patients, spasticity 
becomes progressively worse during the disease course and is prevalent in older patients, 
and tendon reflexes remain preserved throughout the disease, except for ankle jerks 
(Bouchard et al., 1978; El Euch-Fayache et al., 2003). Since we did not observe the two above 
patients in their childhood, we were not able to determine whether or not their spasticity 
had decreased during the disease course or had been absent from the onset (Shimazaki et al., 
2005). The cases without spasticity, this depended on the fact that the neuromuscular 
manifestations were severe enough to diminish muscle tone and masked spasticity, and the 
planter responses were extensor, demonstrating that pyramidal tract sign was present. 
Recently, however, we observed another ARSACS patient whose spasticity had 
disappeared, probably due to the progressive peripheral nerve degeneration in the disease 
course of 29 years (Shimazaki et al., 2007). Thus, we should recognize that there is a rare 
ARSACS phenotype without spasticity, and the SACS gene should be analyzed even in 
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cases of early-onset cerebellar ataxia without spasticity. After that, several reports on 
spasticity-lacking ARSACS patients were published (Hara et al., 2007; Baets et al., 2010; 
Miyatake et al., 2011). 
Second, intellectual impairment is sometimes found in non-Quebec patients. The verbal IQ 
was 58, 88, 100, and 66 (mean: 78.00) in the four Japanese patients we examined (Takiyama, 
2006). Similarly, mental retardation and dementia have been found in Italy (Criscuolo et al., 
2004), Japan (Hara et al., 2005), and Turkey (Richter et al., 2004). Meanwhile, the verbal IQ 
(mean: 92.67) of Quebec patients is considered to be within normal limits, and a number of 
ARSACS patients have completed the secondary and university levels of education 
(Bouchard, 1991). Thus, intellectual impairment seems to be variable in ARSACS. Since the 
mode of inheritance of ARSACS is autosomal recessive, genes other than SACS might 
influence the intellectual impairment. 
Defects in conjugate pursuit ocular movements, decreased or absent vibration sense in the 
toes, hand deformities, and urinary or fecal incontinence are rather frequently noted in 
Quebec (Bouchard, 1991) and non-Quebec patients (El Euch-Fayache et al., 2003; Takiyama, 
2006). Cardiovascular evaluation revealed mitral valve prolapse in a majority of Quebec 
patients examined (Bouchard, 1991). 
Very recently, the disease initially presented with symptoms mainly orienting toward 
peripheral neuropathy in several patients, and there was one patient who did not exhibit 
any clinical or electrophysiologic signs of peripheral neuropathy (Baets et al., 2010).  
4.3 Ophthalmologic findings 
Although increased visibility of myelinated retinal nerve fibers is a hallmark of ARSACS in 
Quebec patients (Bouchard, 1991), there have been a considerable number of non-Quebec 
patients without this characteristic sign for ARSACS (El Euch-Fayache et al., 2003; Grieco et 
al., 2004; Criscuolo et al., 2004; Richter et al., 2004; Hara et al., 2005; Yamamoto et al., 2005; 
Ouyang et al., 2006; Okawa et al., 2006; Yamamoto et al., 2006; Hara et al., 2007; Baets et al., 
2010). Thus, retinal hypermyelination is a variable feature in non-Quebec patients. It is, 
however, very useful for suspecting a diagnosis of ARSACS, especially in an unusual 
phenotype without spasticity (Shimazaki et al., 2005). In a case without retinal 
hypermyelination, ARSACS resembles conditions referred to as early onset cerebellar ataxia 
with retained tendon reflexes (EOCA) (Chio et al., 1993), Friedreich ataxia with retained 
reflexes (De Castro et al., 1999), and several clinical descriptions of hereditary spastic 
paraplegia such as SPG7 (Wilkinson et al., 2004),  SPG21 (Simpson et al., 2003), SPG27 
(Meijer et al., 2004), and SPG30 (Klebe et al., 2006). 
Recently, Desserre et al. have reported that the retinal nerve fiber layer was thickened, as 
shown using optical coherence tomography (OCT), and that the retina did not show 
hypermyelinated areas on funduscopy (Desserre et al., 2011). Likewise, Vingolo et al. 
reported that four patients with ARSACS showed myelinated fibers on funduscopy, and 
also increased thickness of the retina on OCT, which is a finding not characteristic of 
persistent myelination of the retina (Vingolo et al., 2011). It is possible that persistent 
myelination of the retina, a general common finding, was present in those patients without 
bearing relation to the disease.  
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5. Neuroradiology 
5.1 Brain MRI findings 
Some reports have mentioned that characteristic MRI findings in ARSACS are superior 
cerebellar vermian atrophy and cervical spinal cord atrophy (Bouchard et al., 1998; 
Takiyama, 2007). Recently, MRI of five patients in Quebec revealed linear hypointensity in 
T2- and Fluid-Attenuated Inversion Recovery (FLAIR) images of the pons (Martin et al., 
2007). Thereafter, the same findings have been reported in only one patient in each of the 
Netherlands (Van Damme et al., 2009), France (Anheim et al., 2010), and Italy (Terracciano et 
al., 2010). 
We recruited six ARSACS patients with SACS mutations in four Japanese families. Brain 
MRI was performed in all six patients. Brain MRI in the six patients showed superior 
cerebellar vermian atrophy. In addition, not only pontine linear hypointensity but also 
middle cerebellar peduncle hypointensity was observed in T2-weighted and FLAIR images 
(Shimazaki et al., in press) (Table 2). These areas showed isointensity in T1-weighted 
images. Figure 3 shows representative brain MRI findings in patients 3 (A) and 2 (B). In 
patient 3, T2*-weighted images were obtained showing no abnormal findings in the pons 
and middle cerebellar peduncles (Figure 3, A-1).  
We found the characteristic MRI findings in the six Japanese ARSACS patients, who all 
exhibited linear hypointensity in the pons, and a hypointense area in the middle cerebellar 
peduncles in T2-weighted and FLAIR images (Shimazaki et al., in press). A middle 
cerebellar peduncle hypointense area has not previously been reported in ARSACS patients, 
although pontine linear hypointensity was originally reported in five Quebec patients 
(Martin et al., 2007). Furthermore, as far as we know, hypointensity in these portions has not 
been described as a MRI finding in spinocerebellar ataxias and hereditary spastic 
paraplegias.  
We thought these hypointense areas were close to the location of the pontocerebellar fibers. 
We could find low intensity in the middle cerebellar peduncle (MCP) because the 
pontocerebellar fiber runs from the middle pons to the cerebellum through the MCP. We 
can detect low MCP intensity in an Italian case (Terracciano et al., 2010). We think an 
abnormal MCP signal is not specific for Japanese patients. 
The hypointensity in the pons and middle cerebellar peduncle might be specific findings for 
ARSACS cases even in non-Quebec ones with clinical heterogeneity (Shimazaki et al., 2012). 
Thus, pontine and middle cerebellar peduncle T2 hypointensity detectable on MRI should 
prompt us to perform SACS gene analysis even in such atypical early-onset cerebellar ataxia 
cases.  
5.2 Spinal MRI findings 
In Quebec cases, the cervical cord is small and flat (Bouchard, 1991). In our cases, upper 
cervical cord and medulla oblongata atrophy was not observed in three of the six patients 
for whom cervical MRI was performed (Shimazaki et al., 2012). Upper cervical atrophy is 
not a constant feature of ARSACS. In thirteen Belgium cases, cervical spinal cord atrophy 
was observed on MRI in only one case (Baets et al., 2010).  
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Case 1 2 3 4 5 6 
Age at exam, 
gender 
47, F 43, M 46, M 37, M 33, M 57, F 
Age at onset 6 6 3 8 7 3 
Cerebellar 
ataxia 
++ + ++ + ++ ++ 
Hyperreflexia + + + - - - 
Leg spasticity + + + - - - 
Babinski sign + + + + + + 
Retinal 
myelinated 
fibers 
+ + + + + + 
Peripheral 
neuropathy 
+ + + + + + 
Mental 
impairment 
NE +(WAIS-R) +(WAIS-R) NE +(WAIS-R) +(MMSE) 
Amino acid 
substitutions
 W3248R  W3248R W3248R   F1054S
 
F1054S D1996fsX1999 
Superior 
cerebellar 
vermian 
atrophy 
+ + + + + + 
Pontine linear 
hypointensity 
(T2) 
+ + + + + + 
MCP 
hypointensity 
(T2) 
+ + + + + + 
Medulla 
oblongata 
atrophy 
- - + + + - 
Upper cervical 
cord atrophy 
- - + + + - 
Superior 
cerebellar  
CBF decrease 
+- NE +- + + + 
 
Table 2. Clinical, genetic and MRI findings in the ARSACS patients. NE: not examined; 
MCP: Middle cerebellar peduncle; CBF: cerebral blood flow in SPECT. 
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Fig. 3. Representative brain MRI findings in two ARSACS patients. T2-weighted and FLAIR 
images of patient 3 (A-2a, 2b, 4a, and 4b) and patient 2 (B-1, 2a, 2b, 4a, and 4b) showed 
hypointensity in the pons (arrowheads) and bilateral middle cerebellar peduncles (arrows). 
Sagittal sections (A-3 and B-3) revealed superior cerebellar vermian atrophy in all patients. 
A T2* image of patient 3 (A-1) disclosed no remarkable low intensity in the pontine 
tegmentum or cerebellar peduncles (Shimazaki et al., 2012). 
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5.3 SPECT findings  
Single photon emission computed tomography (SPECT) of the brain with three-dimensional 
stereotactic surface projection (3D-SSP) analysis for five cases showed decreased blood flow 
in the upper cerebellar vermis in three cases (Shimazaki et al., 2007; Shimazaki, Nakano, and 
Takiyama, 2008) (Figure 4). Meanwhile, early onset cerebellar ataxia with retained tendon 
reflexes (EOCA) and Friedreich’s ataxia often show a reduction in the parietotemporal 
cortex blood flow as well as cerebellar hypoperfusion (De Michele et al., 1998), this being a 
different feature from in ARSACS. 
 
Fig. 4. 123I-IMP SPECT with three-dimensional stereotactic surface projection (3D-SSP) 
analyses of cases 4, 5, and 6.  
The results showed decreased blood flow in the superior cerebellar vermis and cerebellar 
hemisphere.  
6. Neuropathology 
6.1 Postmortem autopsy and comparison with the characteristic brain MRI findings    
The pathological findings in ARSACS patients have only been reported in a 21-year-old man 
(Bouchard, 1991) and a  59-year-old man (Richter et al., 1996). The former report of a young 
man described no findings regarding pontocerebellar fibers, but mentioned a small 
corticospinal tract and normal pontine nuclei in the pons (Bouchard, 1991). A T2* image of 
patient 3 disclosed no remarkable low intensity in the pontine tegmentum or cerebellar 
peduncles. These findings suggest that T2 hypointensity in the pons and cerebellar 
peduncles is not reflected by iron deposition in these portions. However, a second autopsy 
on the 59-year-old man revealed the presence of swollen thalamic and cerebellar cortical 
neurons (Bouchard et al., 1998). Most of these neurons had dense, lipofuscin-like granules 
within their lysosomes, and the authors suggested that ARSACS may be a lysosomal storage 
disease (Richter et al., 1996). In neuronal ceroid lipofuscinosis, MRI can often reveal 
hypointensity of the thalamus and putamen in T2-weighted images, which may reflect the 
storage of lipofuscin and the increase in the viscosity in these neurons (Autti, Joensuu, and 
Aberg, 2007). Therefore, the linear hypointensity of the pons that was found among 
ARSACS patients can also be explained by possible storage of lipofuscin-like materials. 
Further pathological study is needed to disclose the origin of the T2 hypointensity.  
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6.2 Nerve and muscle biopsy 
Sural nerve biopsy revealed severe axonal degeneration and loss of large myelinated fibers 
(Peyronnard, Charron, and Barbeau, 1979; Bouchard, 1991; El Euch-Fayache et al., 2003; 
Takiyama, 2006). These findings in Quebec and non-Quebec patients are consistent with an 
axonal neuropathy associated with demyelinating features. 
Muscle biopsy disclosed typical and obvious neurogenic atrophy, i.e., grouped atrophy in 
the studied patients (Bouchard, 1991; El Euch-Fayache et al., 2003).  
7. Neurophysiology 
7.1 Peripheral nerve conduction studies 
The peripheral nerve conduction study in Quebec patients revealed an axonal neuropathy 
with absent sensory action potentials and low motor conduction velocity (Peyronnard, 
Charron, and Barbeau, 1979; Bouchard, 1991). We have presented the peripheral nerve 
conduction data for cases 4 and 5 (Shimazaki et al., 2005). In each patient, the motor nerve 
conduction velocity was mildly reduced in the ulnar and median nerves, and moderately in 
the posterior tibial nerves. Each compound muscle action potential (CMAP) was markedly 
decreased. In case 5 (patient 1 of (Shimazaki et al., 2005)), a CMAP was not evoked in the 
common peroneal nerves. No sensory nerve action potential was evoked in any of the 
extremities. These data indicate not only a severe to moderate axonal neuropathy but 
dysmyelinating neuropathy complicated by secondary axonal degeneration as in Quebec 
and Tunisian patients (Peyronnard, Charron, and Barbeau, 1979; El Euch-Fayache et al., 
2003). 
7.2 Motor and sensory evoked potentials 
Central pathway conduction studies including ones on somatosensory evoked potentials, 
brainstem auditory evoked potentials, and pattern reversal visual evoked potentials were 
performed in 67 Quebec patients (De Lean, Mathieu, and Bouchard, 1989). The findings that 
showed marked delays revealed widespread processes of demyelination in the primary 
sensory neurons as well as in the central nervous system (Bouchard, 1991). The central 
sensory and motor pathways were markedly impaired that could be attributed to 
myelinopathies, and there were high incidences of asymptomatic auditory and visual 
pathway involvement (Bouchard, 1991). 
Electronystagmography showed horizontal gaze nystagmus in all Quebec patients with 
marked impairment of smooth ocular pursuit and optokinetic nystagmus, and defective 
fixation suppression of caloric nystagmus (Dionne et al., 1979). Recently, both the masseter 
and blink reflexes were found to be abnormal in two ARSACS patients (Garcia et al., 2008), 
whereas the masseter reflex was preserved but a bilateral delay of the late response of the 
blink reflex was observed in Friedreich’ ataxia patients.  
8. Therapy and management 
Spasticity, the main feature of ARSACS during childhood, is rather mild in most patients. In 
the teens, however, the  spasticity increases in the lower limbs and patients often present a 
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spastic gait with evolving pes cavus (Bouchard et al., 2007). Physical therapy and use of oral 
medications such as baclofen to control spasticity in the early phase of the disease may 
prevent tendon shortening and joint contractures. When spasticity becomes significant, 
intrathecal baclofen may be considered. The most effective surgical procedures were triple 
arthrodesis with percutaneous lengthening of the Achilles tendon, and adductor and psoas 
tenotomies combined with neurectomy of the obturator nerve for perineal hygiene in a 
retrospective study of 26 patients who received surgical orthopaedic treatment (Bouchard 
and Langlois, 1999).  
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